Preliminary results of V3 loop peptide-primary neutralizing domain conjugate phase 1 vaccine trail.
Rubinstein
A
A
Department of Pediatrics, Microbiology, and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461.
Goldstein
H
H
Pettoello-Mantovani
M
M
Cryz
S J
SJ
D016915:AIDS Vaccines / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology*; D000595:Amino Acid Sequence; D003429:Cross Reactions; D015483:HIV Antibodies / Q000097:blood; D015488:HIV Antigens / Q000235:genetics; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000276:immunology*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007115:Immunization Schedule; D007074:Immunoglobulin G / Q000097:blood / Q000145:classification; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology*; D012449:Safety; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014373:Tuberculin / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D014374:Tuberculin Test; D018074:Vaccines, Conjugate / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology
D016915:AIDS Vaccines; D015483:HIV Antibodies; D015488:HIV Antigens; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D007074:Immunoglobulin G; D010446:Peptide Fragments; D014373:Tuberculin; D018074:Vaccines, Conjugate